Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima; Akiko Kada; Akihiko Tanizawa; Yuki Yuza; Akihiro Watanabe; Masaki Ito; Hideko Uryu; Katsuyoshi Koh; Chihaya Imai; Nao Yoshida; Yuhki Koga; Naoto Fujita; Akiko M. Saito; Souichi Adachi; Eiichi Ishii; Hiroyuki Shimada

doi:10.1182/blood-2019-122623

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

Haruko Shima, Akiko Kada, Akihiko Tanizawa, Yuki Yuza, Akihiro Watanabe, Masaki Ito, Hideko Uryu, Katsuyoshi Koh, Chihaya Imai, Nao Yoshida, Yuhki Koga, Naoto Fujita, Akiko M. Saito, Souichi Adachi, Eiichi Ishii, Hiroyuki Shimada

医学研究院

研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

2 被引用数 (Scopus)

抄録

DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

本文言語	英語
ページ数	1
ジャーナル	Blood
巻	134
号	1
DOI	https://doi.org/10.1182/blood-2019-122623
出版ステータス	出版済み - 11月 13 2019

!!!All Science Journal Classification (ASJC) codes

生化学
免疫学
血液学
細胞生物学

文献へのアクセス

10.1182/blood-2019-122623

他のファイルとリンク

引用スタイル

@article{de9bc9f5dcfd45c5bf8c9c121bd7625c,

title = "Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)",

abstract = "DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.",

author = "Haruko Shima and Akiko Kada and Akihiko Tanizawa and Yuki Yuza and Akihiro Watanabe and Masaki Ito and Hideko Uryu and Katsuyoshi Koh and Chihaya Imai and Nao Yoshida and Yuhki Koga and Naoto Fujita and Saito, {Akiko M.} and Souichi Adachi and Eiichi Ishii and Hiroyuki Shimada",

year = "2019",

month = nov,

day = "13",

doi = "10.1182/blood-2019-122623",

language = "English",

volume = "134",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

AU - Shima, Haruko

AU - Kada, Akiko

AU - Tanizawa, Akihiko

AU - Yuza, Yuki

AU - Watanabe, Akihiro

AU - Ito, Masaki

AU - Uryu, Hideko

AU - Koh, Katsuyoshi

AU - Imai, Chihaya

AU - Yoshida, Nao

AU - Koga, Yuhki

AU - Fujita, Naoto

AU - Saito, Akiko M.

AU - Adachi, Souichi

AU - Ishii, Eiichi

AU - Shimada, Hiroyuki

PY - 2019/11/13

Y1 - 2019/11/13

N2 - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

AB - DISCLOSURES: Kada: Bayer Yakuhin: Other: personal fees for a member of independent data monitoring committee of clinical trials, outside of the submitted work.. Imai:Juno Therapeutics: Patents & Royalties.

UR - http://www.scopus.com/inward/record.url?scp=85074959207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074959207&partnerID=8YFLogxK

U2 - 10.1182/blood-2019-122623

DO - 10.1182/blood-2019-122623

M3 - Article

C2 - 31724002

VL - 134

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -

Discontinuation of Tyrosine Kinase Inhibitor in Children with Chronic Myeloid Leukemia (JPLSG STKI-14 study)

抄録

!!!All Science Journal Classification (ASJC) codes

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル